Chargement en cours...

Nanobodies effectively modulate the enzymatic activity of CD38 and allow specific imaging of CD38(+) tumors in mouse models in vivo

The cell surface ecto-enzyme CD38 is a promising target antigen for the treatment of hematological malignancies, as illustrated by the recent approval of daratumumab for the treatment of multiple myeloma. Our aim was to evaluate the potential of CD38-specific nanobodies as novel diagnostics for hema...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Sci Rep
Auteurs principaux: Fumey, William, Koenigsdorf, Julia, Kunick, Valentin, Menzel, Stephan, Schütze, Kerstin, Unger, Mandy, Schriewer, Levin, Haag, Friedrich, Adam, Gerhard, Oberle, Anna, Binder, Mascha, Fliegert, Ralf, Guse, Andreas, Zhao, Yong Juan, Cheung Lee, Hon, Malavasi, Fabio, Goldbaum, Fernando, van Hegelsom, Rob, Stortelers, Catelijne, Bannas, Peter, Koch-Nolte, Friedrich
Format: Artigo
Langue:Inglês
Publié: Nature Publishing Group UK 2017
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5662768/
https://ncbi.nlm.nih.gov/pubmed/29084989
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-017-14112-6
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!